The boring life of Jerod Poore, Crazymeds' Chief Citizen Medical Expert.

Happy Fucking New Year. Those Mayans had best be right about 2012.

Nothing starts the new year right like a fuel tank lid refusing to come off, a blinking "check engine" light, and spiraling into depression.  So much for driving into Missoula early New Year's day, so I could deal with shit when everyone was hungover and the stores wouldn't be too crowded.

I've had plenty more to whine about for the last two months, but I didn't want to write about it.  What little functionality I've had has been devoted to keeping my life barely together or working on Crazy Meds - mostly behind-the-scenes crap.  I've become socially avoidant to the point of rarely answering e-mail and just occasionally checking in on the Crazy Meds forum.  That's it.  Not this blog - the blogrolls need a lot of pruning - let alone other blogs, no other sites, nothing.  I'll use my laptop exclusively as a radio for days at a time.  I haven't been depressed.  Sunday was the first time I felt real, near-suicidal depression in months, maybe more than a year, and I'm already getting over it.  I'm just fed up with clogged drainpipes that prevent the washing machine from working, and yet another mystery leak in the plumbing, and all the other problems people in Haiti wished they had.

I did find one thing that still cracks me up.  Best off-label application ever:


Exorcism-resistant ghost possession treated with clopenthixol.

Background: An Indian man now in Britain explained his criminal behaviour as episodic ghost possession. Traditional exorcisms failed to help.
Method: A 'Western' diagnosis of dissociative state or paranoid schizophrenia was made. Treatment commenced using trifluoperazine and clopenthixol.
Results: The patient underwent remission during neuroleptic treatment, despite previous evidence of genuine possession.
Conclusions: Many cultures give rise to apparently genuine cases of ghost possession. Neuroleptics may relieve symptoms of exorcism-resistant possession.

No comments: